Search Results - "Kipriyanov, Sergey M."

Refine Results
  1. 1

    Antibody expressing pea seeds as fodder for prevention of gastrointestinal parasitic infections in chickens by Zimmermann, Jana, Saalbach, Isolde, Jahn, Doreen, Giersberg, Martin, Haehnel, Sigrun, Wedel, Julia, Macek, Jeanette, Zoufal, Karen, Glünder, Gerhard, Falkenburg, Dieter, Kipriyanov, Sergey M

    Published in BMC biotechnology (11-09-2009)
    “…Coccidiosis caused by protozoans of genus Eimeria is a chicken parasitic disease of great economical importance. Conventional disease control strategies depend…”
    Get full text
    Journal Article
  2. 2

    Effect of Domain Order on the Activity of Bacterially Produced Bispecific Single-chain Fv Antibodies by Kipriyanov, Sergey M., Moldenhauer, Gerhard, Braunagel, Michael, Reusch, Uwe, Cochlovius, Björn, Le Gall, Fabrice, Kouprianova, Olga A., Von der Lieth, Claus-Wilhelm, Little, Melvyn

    Published in Journal of molecular biology (27-06-2003)
    “…Bispecific single-chain Fv antibodies comprise four covalently linked immunoglobulin variable (VH and VL) domains of two different specificities. Depending on…”
    Get full text
    Journal Article
  3. 3

    Generation of bispecific and tandem diabodies by Kipriyanov, Sergey M

    “…Conventionally, antibody phage display has been used to isolate recombinant antibodies that are monovalent in their interaction with target antigens. These…”
    Get more information
    Journal Article
  4. 4

    High-level periplasmic expression and purification of scFvs by Kipriyanov, Sergey M

    “…The isolation of recombinant antibodies by phage display naturally leads to experiments to evaluate their biological and immunological properties. Although…”
    Get more information
    Journal Article
  5. 5

    The Antigen-Binding Domain of a Human IgG-Anti-F(ab′)2 autoantibody by Welschof, Martin, Terness, Peter, Kipriyanov, Sergey M., Stanescu, Diana, Breitling, Frank, Dörsam, Heinz, Dübel, Stefan, Little, Melvyn, Opelz, Gerhard

    “…Recent studies revealed an immunoregulatory role of natural IgG-anti-F(ab′)2 antibodies in both healthy individuals and patients with certain diseases. The…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics by Kipriyanov, Sergey M, Moldenhauer, Gerhard, Schuhmacher, Jochen, Cochlovius, Björn, Von der Lieth, Claus-Wilhelm, Matys, E.Ronald, Little, Melvyn

    Published in Journal of molecular biology (15-10-1999)
    “…To increase the valency, stability and therapeutic potential of bispecific antibodies, we designed a novel recombinant molecule that is bispecific and…”
    Get full text
    Journal Article
  8. 8

    Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody by Le Gall, Fabrice, Reusch, Uwe, Little, Melvyn, Kipriyanov, Sergey M.

    Published in Protein engineering, design and selection (01-04-2004)
    “…Bispecific single-chain Fv antibodies comprise four covalently linked immunoglobulin variable (VH and VL) domains of two different specificities connected by…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma by Kipriyanov, Sergey M., Cochlovius, Björn, Schäfer, Holger J., Moldenhauer, Gerhard, Bähre, Alexandra, Le Gall, Fabrice, Knackmuss, Stefan, Little, Melvyn

    Published in The Journal of immunology (1950) (01-07-2002)
    “…Abstract To target NK cells against non-Hodgkin’s lymphoma, we constructed a bispecific diabody (BsDb) with reactivity against both human CD19 and FcγRIII…”
    Get full text
    Journal Article
  11. 11

    Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding by Le Gall, Fabrice, Kipriyanov, Sergey M., Moldenhauer, Gerhard, Little, Melvyn

    Published in FEBS letters (18-06-1999)
    “…Single chain variable fragments (scFv) of the murine monoclonal antibody HD37 specific to human B-cell antigen CD19 were constructed by joining the V H and V L…”
    Get full text
    Journal Article
  12. 12
  13. 13

    High level production of soluble single chain antibodies in small-scale Escherichia coli cultures by Kipriyanov, Sergey M., Moldenhauer, Gerhard, Little, Melvyn

    Published in Journal of immunological methods (15-01-1997)
    “…We have investigated the effect of growth and induction conditions on the production of soluble single-chain Fv antibody fragments in Escherichia coli under…”
    Get full text
    Journal Article
  14. 14

    Generation and production of engineered antibodies by KIPRIYANOV, Sergey M, LE GALL, Fabrice

    Published in Molecular biotechnology (2004)
    “…Various forms of recombinant monoclonal antibodies are being used increasingly, mainly for therapeutic purposes. This review specifically focuses on what is…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Immunosuppressive properties of anti-CD3 single-chain Fv and diabody by Le Gall, Fabrice, Reusch, Uwe, Moldenhauer, Gerhard, Little, Melvyn, Kipriyanov, Sergey M.

    Published in Journal of immunological methods (01-02-2004)
    “…The mouse anti-human CD3 monoclonal antibody OKT3 is a potent immunosuppressive agent used in clinical transplantation. However, OKT3 therapy is associated…”
    Get full text
    Journal Article
  19. 19

    Generation of recombinant antibodies by KIPRIYANOV, S. M, LITTLE, M

    Published in Molecular biotechnology (01-09-1999)
    “…Recombinant antibody technology is opening new perspectives for the development of novel therapeutic and diagnostic agents. In this review we focus on advances…”
    Get full text
    Journal Article
  20. 20